Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ: EKSO · IEX Real-Time Price · USD
1.82
0.02 (1.11%)
May 20, 2022 4:00 PM EDT - Market closed
Market Cap23.38M
Revenue (ttm)11.90M
Net Income (ttm)-10.71M
Shares Out12.84M
EPS (ttm)-0.93
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,695
Open1.85
Previous Close1.80
Day's Range1.81 - 1.86
52-Week Range1.54 - 6.10
Beta1.94
AnalystsBuy
Price Target11.22 (+516.5%)
Earnings DateApr 28, 2022

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provide...

IndustryHealth Care Equipment & Supplies
Founded2005
CEOJack Peurach
Employees55
Stock ExchangeNASDAQ
Ticker SymbolEKSO
Full Company Profile

Financial Performance

In 2021, EKSO's revenue was $11.25 million, an increase of 26.62% compared to the previous year's $8.88 million. Losses were -$9.76 million, -38.30% less than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is 11.22, which is an increase of 516.48% from the latest price.

Price Target
$11.22
(516.48% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Ekso Bionics (EKSO) Could Find Support Soon, Here's Why You Should Buy the Stock Now

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wal...

1 week ago - Zacks Investment Research

Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Ekso Bionics Reports First Quarter 2022 Results

RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...

3 weeks ago - GlobeNewsWire

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

1 month ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022

RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...

3 months ago - GlobeNewsWire

Ekso Bionics Announces Leadership Transition

Board Member Steven Sherman to be Appointed CEO

3 months ago - GlobeNewsWire

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million 1

4 months ago - GlobeNewsWire

Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference

RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that manageme...

4 months ago - GlobeNewsWire

Ekso Bionics Appoints Corinna E. Lathan, Ph.D.

RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...

4 months ago - GlobeNewsWire

Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles

- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -

5 months ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 32.00% and 18.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Ekso Bionics Reports Third Quarter 2021 Results

RICHMOND, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reporte...

6 months ago - GlobeNewsWire

Ekso Bionics to Report Third Quarter 2021 Financial Results on November 2, 2021

RICHMOND, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...

6 months ago - GlobeNewsWire

Ekso Bionics to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference

RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that managem...

8 months ago - GlobeNewsWire

Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -4.00% and 3.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Ekso Bionics Reports Second Quarter 2021 Results

RICHMOND, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reporte...

9 months ago - GlobeNewsWire

Will Ekso Bionics (EKSO) Report Negative Q2 Earnings? What You Should Know

Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

New Strong Sell Stocks for May 27th

AFYA, BNL, CLBS, EKSO, and LLY have been added to the Zacks Rank #5 (Strong Sell) List on May 27, 2021

Other symbols:AFYABNLCLBSLLY
11 months ago - Zacks Investment Research

Moving Average Crossover Alert: Ekso Bionics (EKSO)

Ekso Bionics (EKSO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

1 year ago - Zacks Investment Research

Ekso Bionics Holdings: Q1 Earnings Insights

Shares of Ekso Bionics Holdings (NASDAQ:EKSO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 22.73% year over year to ($0.34), which m...

1 year ago - Benzinga

Ekso Bionics Reports First Quarter 2021 Results

RICHMOND, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...

1 year ago - GlobeNewsWire

Will Ekso Bionics (EKSO) Report Negative Q1 Earnings? What You Should Know

Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Ekso Bionics to Report First Quarter 2021 Financial Results on April 29, 2021

RICHMOND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will...

1 year ago - GlobeNewsWire

Ekso Bionics (EKSO) Surges 9.4%: Is This an Indication of Further Gains?

Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...

1 year ago - Zacks Investment Research